RegeneRx Biopharmaceuticals, Inc. (RGRX)
OTCMKTS · Delayed Price · Currency is USD
0.1730
0.00 (0.00%)
At close: Oct 27, 2026
RGRX Market Cap
RGRX has a market cap or net worth of $260.99 thousand as of October 30, 2026. It is the 50,815th most valuable company in the world and the 7,075th biggest in the United States. Its market cap has increased by 7.45% in one year.
Market Cap
260.99K
Enterprise Value
n/a
Revenue
76.76K
Global Rank
Country Rank
#7,075 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since June 16, 1987, RGRX's market cap has decreased from 58.65M to 260.99K, a decrease of -99.56%. That is a compound annual growth rate of -12.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 1.66K | 266.23% |
| Dec 31, 2025 | 453.00 | -78.55% |
| Dec 26, 2024 | 2.11K | 16.69% |
| Dec 29, 2023 | 1.81K | -99.99% |
| Dec 30, 2022 | 19.94M | -13.19% |
| Dec 31, 2021 | 22.97M | -61.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Altamira Therapeutics | 404.66K |
| Aditxt | 399.19K |
| Actavia Life Sciences | 385.91K |
| CNBX Pharmaceuticals | 385.15K |
| Lyra Therapeutics | 337.23K |
| THC Farmaceuticals | 320.93K |
| Nextel Medical | 305.95K |
| CERo Therapeutics Holdings | 303.69K |